Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126257451 | 12625745 | 1 | I | 20160613 | 20160729 | 20160805 | 20160805 | EXP | FR-PFIZER INC-2016374609 | PFIZER | 69.00 | YR | M | Y | 0.00000 | 20160805 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126257451 | 12625745 | 1 | PS | CORDARONE | AMIODARONE HYDROCHLORIDE | 1 | Oral | UNK | Y | 18972 | TABLET | ||||||||
| 126257451 | 12625745 | 2 | SS | BISOPROLOL | BISOPROLOL | 1 | Oral | 1.5 DF, 2X/DAY | 18 | DF | Y | 0 | 1.5 | DF | FILM-COATED TABLET | BID | |||
| 126257451 | 12625745 | 3 | SS | AMOXICILLIN/CLAVULANIC ACID SANDOZ | AMOXICILLINCLAVULANIC ACID | 1 | Oral | UNK | Y | 0 | |||||||||
| 126257451 | 12625745 | 4 | SS | PREVISCAN | FLUINDIONE | 1 | Oral | 0.5 DF, DAILY | Y | 0 | .5 | DF | |||||||
| 126257451 | 12625745 | 5 | SS | FLAGYL | METRONIDAZOLEMETRONIDAZOLE HYDROCHLORIDE | 1 | Oral | UNK | Y | 0 | |||||||||
| 126257451 | 12625745 | 6 | C | AMAREL | GLIMEPIRIDE | 1 | UNK | 0 | |||||||||||
| 126257451 | 12625745 | 7 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | UNK | 0 | |||||||||||
| 126257451 | 12625745 | 8 | C | KARDEGIC | ASPIRIN LYSINE | 1 | UNK | 0 | |||||||||||
| 126257451 | 12625745 | 9 | C | ADENURIC | FEBUXOSTAT | 1 | UNK | 0 | |||||||||||
| 126257451 | 12625745 | 10 | C | TRAMADOL. | TRAMADOL | 1 | UNK | 0 | |||||||||||
| 126257451 | 12625745 | 11 | C | LASILIX | FUROSEMIDE | 1 | UNK (10MG/H) | 0 | |||||||||||
| 126257451 | 12625745 | 12 | C | LEVEMIR | INSULIN DETEMIR | 1 | UNK | 0 | |||||||||||
| 126257451 | 12625745 | 13 | C | NOVORAPID | INSULIN ASPART | 1 | UNK | 0 | |||||||||||
| 126257451 | 12625745 | 14 | SS | PARACETAMOL | ACETAMINOPHEN | 1 | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126257451 | 12625745 | 3 | Skin ulcer |
| 126257451 | 12625745 | 5 | Skin ulcer |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126257451 | 12625745 | HO |
| 126257451 | 12625745 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126257451 | 12625745 | Drug-induced liver injury | |
| 126257451 | 12625745 | Renal failure | |
| 126257451 | 12625745 | Vascular purpura |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126257451 | 12625745 | 1 | 20160608 | 0 | ||
| 126257451 | 12625745 | 2 | 20160608 | 20160617 | 0 | |
| 126257451 | 12625745 | 3 | 20160608 | 20160617 | 0 | |
| 126257451 | 12625745 | 4 | 20160608 | 20160617 | 0 | |
| 126257451 | 12625745 | 5 | 20160608 | 20160617 | 0 | |
| 126257451 | 12625745 | 11 | 20160617 | 0 |